Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nucl Med Biol. 2013 Mar 23;40(4):498–506. doi: 10.1016/j.nucmedbio.2012.12.013

Table 1.

Biodistribution of [18F]9a in BALB/c mice with subcutaneous DBT tumors. Mice were anesthetized with 1% isoflurane/oxygen and 20–30 μCi (0.74 – 1.1 MBq) of [18F]9a was administered via tail vein injection. The animals were euthanized in groups of 4 animals at 5, 30 and 60 minutes post injection.

5 min 30 min 60 min
blood 4.53 ± 0.34 1.21 ± 0.17 0.28 ± 0.09
bone 1.54 ± 0.26 1.49 ± 1.68 0.44 ± 0.23
brain 0.33 ± 0.07 0.25 ± 0.04 0.09 ± 0.03
fat 0.89 ± 0.19 0.24 ± 0.09 0.17 ± 0.16
heart 3.09 ± 0.46 1.20 ± 0.15 0.30 ± 0.11
kidney 15.93 ± 1.57 4.39 ± 0.48 1.11 ± 0.34
liver 4.11 ± 0.19 1.12 ± 0.09 0.29 ± 0.11
lung 3.81 ± 0.19 1.06 ± 0.16 0.26 ± 0.10
muscle 2.26 ± 0.36 1.35 ± 0.27 0.52 ± 0.27
pancreas 21.03 ± 2.23 5.99 ± 1.60 1.64 ± 0.72
salivary gland 3.44 ± 0.31 0.92 ± 0.14 0.25 ± 0.10
spleen 3.79 ± 0.32 1.07 ± 0.15 0.28 ± 0.12
thyroid 2.93 ± 0.50 0.97 ± 0.13 0.35 ± 0.12
tumor 3.28 ± 0.82 2.17 ± 0.36 0.82 ± 0.37

The data are expressed as %ID/g with the exception of the thyroid which is expressed as %ID/organ. Error is expressed as standard deviation. n = 3 or 4 for each value.